FDA "Import For Export" Rule Burdensome To Industry - PhRMA
This article was originally published in The Tan Sheet
Executive Summary
FDA's "import for export" proposed rule would put U.S. drug manufacturers at a competitive disadvantage in the international market, the Pharmaceutical Research & Manufacturers of America maintains in Feb. 8 comments to the agency.